164 related articles for article (PubMed ID: 11563298)
1. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.
Krayenbühl N; Hegner T; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():247-50. PubMed ID: 11563298
[No Abstract] [Full Text] [Related]
2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
3. Antiischemic therapy of severe prolonged vasospasm after aneurysmal SAH: effects on quality of life.
Kreitschmann-Andermahr I; Hütter BO; Gilsbach JM
Acta Neurochir Suppl; 2001; 77():251-4. PubMed ID: 11563300
[No Abstract] [Full Text] [Related]
4. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
5. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
6. Bedside monitoring of cerebral blood flow in patients with subarachnoid hemorrhage.
Hegner T; Krayenbühl N; Hefti M; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():131-4. PubMed ID: 11563271
[No Abstract] [Full Text] [Related]
7. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
8. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
10. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.
Origitano TC; Wascher TM; Reichman OH; Anderson DE
Neurosurgery; 1990 Nov; 27(5):729-39; discussion 739-40. PubMed ID: 2259403
[TBL] [Abstract][Full Text] [Related]
11. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Igarashi Y; Yokota H;
Neurocrit Care; 2014 Dec; 21(3):462-9. PubMed ID: 24865266
[TBL] [Abstract][Full Text] [Related]
12. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
13. [Two patients treated with intra-aortic balloon pump counterpulsation after subarachnoid hemorrhage].
Sato K; Tokairin H; Kato M
Masui; 2001 Aug; 50(8):859-62. PubMed ID: 11554017
[TBL] [Abstract][Full Text] [Related]
14. The present role of "triple-H" therapy in the management of cerebral vasospasm.
Findlay JM
World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
[No Abstract] [Full Text] [Related]
15. Cardiac performance enhancement and hypervolemic therapy.
Levy ML; Day JD; Zelman V; Giannotta SL
Neurosurg Clin N Am; 1994 Oct; 5(4):725-39. PubMed ID: 7827481
[TBL] [Abstract][Full Text] [Related]
16. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage.
Mutoh T; Kazumata K; Ishikawa T; Terasaka S
Stroke; 2009 Jul; 40(7):2368-74. PubMed ID: 19461028
[TBL] [Abstract][Full Text] [Related]
17. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
Darwish RS; Ahn E; Amiridze NS
J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
[TBL] [Abstract][Full Text] [Related]
18. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
Meyer R; Deem S; Yanez ND; Souter M; Lam A; Treggiari MM
Neurocrit Care; 2011 Feb; 14(1):24-36. PubMed ID: 20838932
[TBL] [Abstract][Full Text] [Related]
19. Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.
Romner B; Reinstrup P
Acta Neurochir Suppl; 2001; 77():237-41. PubMed ID: 11563296
[No Abstract] [Full Text] [Related]
20. Cerebral vasospasm and delayed cerebral ischemia: Review of literature and the management approach.
Chugh C; Agarwal H
Neurol India; 2019; 67(1):185-200. PubMed ID: 30860121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
